Q&A: What do the recent updates to the Declaration of Helsinki mean for clinical trial technology?
A conversation with Amanda Howley, Director of Services Solutions at Suvoda
Posts by Suvoda Blog:
Improving patient and trial outcomes using eCOA to connect trial data
Author: Andrés Escallón, VP eCOA Practice
Turning Classic Mistakes Into Key Technical Learnings
Author: Andrew McVeigh, Chief Architect
Electronic Clinical Outcome Assessments (eCOA) in Clinical Trials
Snapshot:
- Overview of eCOA: Electronic Clinical Outcome Assessments (eCOA) are digital tools...
4 Factors That Shape a Technical Direction That Lasts
Author: Andrew McVeigh, Chief Architect
Improving Informed Consent: A Closer Look at the Draft FDA Guidance for Patient Understanding
Author: Amanda Howley, Director, Services Delivery
Snapshot:
- Enhanced Patient Understanding: The...
How thoughtful adaptation in clinical trials can bring new medicines to market faster
Author: Zach Hales, Director of Product Management
Snapshot:
- Barriers to Innovation: Structural...
Real-Time Data Benefits for Clinical Research Organizations
Author: Andrés Escallón, VP eCOA Practice
Snapshot:
Enhanced Decision-Making: Real-time data...
How to Choose an IRT Solution For Your Clinical Trial
A framework to identify the right IRT solution for each trial
With increasing protocol complexity,...
Behind the Clinical Trial Technology: A Conversation with Suvoda’s Experts
Suvoda’s Chief Product Officer E.K. Koh and Chief Architect Andrew McVeigh recently sat down to...